Live Quote · OTCKALYHealthcare · Drug Manufacturers - Specialty & Generic

Kali, Inc.

$0.00▲ 0.00%(+$0.00)

TickerSpark Score

62/100

▌ Mixed

60

Valuation

70

Profitability

60

Growth

20

Health

100

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KALY research report →

52-Week Range100% of range

Low

$0.00

Current

$0.00

High

$0.00

Company Overviewwww.kali-extracts.com

About the company

Kali, Inc. , which conducts business as Kali-Extracts, Inc. , focuses its efforts on the research and development of cannabis-based treatments.

CEO: Frederick Ferri
IPO: 2008
Employees: 171
HQ: Dallas, TX, US

Price Chart

+100.00% · this period

Valuation

Market Cap: $101.82K
P/E: -8.55
P/S: 1.56
P/B: -0.19
EV/EBITDA: -54.22
Div Yield: 0.00%

Profitability

Gross Margin: 22.01%
Op Margin: -18.23%
Net Margin: -18.24%
ROE: 3.26%
ROIC: 436.86%

Growth & Income

Revenue: $65.27K · -3.44%
Net Income: $-11,903 · -27.85%
EPS: $-0.00 · 26.26%
Op Income: $-11,900
FCF YoY: 97.34%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: -72.35
Avg Volume: 1.61K

Get TickerSpark's AI analysis on KALY

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · KALY